{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:24:57Z","timestamp":1783488297324,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-025-04234-7","type":"journal-article","created":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T08:34:03Z","timestamp":1745224443000},"page":"283-290","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The prevalence and predictors of Cushing disease recurrence: a 10-year experience of a pituitary tumor center of excellence"],"prefix":"10.1007","volume":"89","author":[{"given":"Elisa","family":"Lamback","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leandro","family":"Kasuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renan Lyra","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila Saggioro","family":"de Figueiredo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Eduardo","family":"Wildemberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f4nica R.","family":"Gadelha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,21]]},"reference":[{"key":"4234_CR1","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","volume":"9","author":"M Fleseriu","year":"2021","unstructured":"M. Fleseriu, R. Auchus, I. Bancos, A. Ben-Shlomo, J. Bertherat, N.R. Biermasz et al., Consensus on diagnosis and management of Cushing\u2019s disease: a guideline update. Lancet Diabetes Endocrinol. 9, 847\u2013875 (2021).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"4234_CR2","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1016\/S0140-6736(23)01961-X","volume":"402","author":"M Gadelha","year":"2023","unstructured":"M. Gadelha, F. Gatto, L.E. Wildemberg, M. Fleseriu, Cushing\u2019s syndrome. Lancet 402, 2237\u20132252 (2023).","journal-title":"Lancet"},{"key":"4234_CR3","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s12020-020-02432-z","volume":"70","author":"LT Braun","year":"2020","unstructured":"L.T. Braun, G. Rubinstein, S. Zopp, F. Vogel, C. Schmid-Tannwald, M.P. Escudero et al., Recurrence after pituitary surgery in adult Cushing\u2019s disease: a systematic review on diagnosis and treatment. Endocrine 70, 218\u2013231 (2020).","journal-title":"Endocrine"},{"key":"4234_CR4","doi-asserted-by":"publisher","first-page":"R227","DOI":"10.1530\/EJE-14-0883","volume":"172","author":"S Petersenn","year":"2015","unstructured":"S. Petersenn, A. Beckers, D. Ferone, A. van der Lely, J. Bollerslev, M. Boscaro et al., Therapy of endocrine disease: outcomes in patients with Cushing\u2019s disease undergoing transsphenoidal surgery: systematic review assessing criteria used to define remission and recurrence. Eur. J. Endocrinol. 172, R227\u2013R239 (2015).","journal-title":"Eur. J. Endocrinol."},{"key":"4234_CR5","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s11102-023-01345-0","volume":"26","author":"A Giustina","year":"2023","unstructured":"A. Giustina, M.M. Uygur, S. Frara, A. Barkan, N.R. Biermasz, P. Chanson et al., Pilot study to define criteria for pituitary tumors centers of excellence (PTCOE): results of an audit of leading international centers. Pituitary 26, 583\u2013596 (2023).","journal-title":"Pituitary"},{"key":"4234_CR6","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s11102-017-0838-2","volume":"20","author":"FF Casanueva","year":"2017","unstructured":"F.F. Casanueva, A.L. Barkan, M. Buchfelder, A. Klibanski, E.R. Laws, J.S. Loeffler et al., Criteria for the definition of pituitary tumor centers of excellence (PTCOE): a pituitary society statement. Pituitary 20, 489\u2013498 (2017).","journal-title":"Pituitary"},{"key":"4234_CR7","doi-asserted-by":"publisher","first-page":"e94","DOI":"10.1210\/clinem\/dgaa773","volume":"106","author":"F Wang","year":"2021","unstructured":"F. Wang, M.P. Catalino, W.L. Bi, I.F. Dunn, T.R. Smith, Y. Guo et al., Postoperative day 1 morning cortisol value as a biomarker to predict long-term remission of cushing disease. J. Clin. Endocrinol. Metab. 106, e94\u2013e102 (2021).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4234_CR8","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/s41574-023-00868-7","volume":"19","author":"M Fleseriu","year":"2023","unstructured":"M. Fleseriu, E.V. Varlamov, J.M. Hinojosa-Amaya, F. Langlois, S. Melmed, An individualized approach to the management of Cushing disease. Nat. Rev. Endocrinol. 19, 581\u2013599 (2023).","journal-title":"Nat. Rev. Endocrinol."},{"key":"4234_CR9","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1007\/s11102-022-01226-y","volume":"25","author":"M Balomenaki","year":"2022","unstructured":"M. Balomenaki, D.A. Vassiliadi, S. Tsagarakis, Cushing\u2019s disease: risk of recurrence following trans-sphenoidal surgery, timing and methods for evaluation. Pituitary 25, 718\u2013721 (2022).","journal-title":"Pituitary"},{"key":"4234_CR10","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/s12020-020-02402-5","volume":"70","author":"EB Lamback","year":"2020","unstructured":"E.B. Lamback, A. Guterres, M.A. Barbosa, C.H.A. Lima, D.A. Silva, A.H.D.S. Camacho et al., Cyclin A in nonfunctioning pituitary adenomas. Endocrine 70, 380\u2013387 (2020).","journal-title":"Endocrine"},{"key":"4234_CR11","doi-asserted-by":"publisher","first-page":"1090144","DOI":"10.3389\/fendo.2022.1090144","volume":"13","author":"CH Koh","year":"2022","unstructured":"C.H. Koh, D.Z. Khan, R. Digpal, H. Layard Horsfall, A.M.S. Ali, S.E. Baldeweg et al., The clinical outcomes of imaging modalities for surgical management Cushing\u2019s disease - a systematic review and meta-analysis. Front. Endocrinol. 13, 1090144 (2022).","journal-title":"Front. Endocrinol."},{"key":"4234_CR12","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.3390\/jcm11061558","volume":"11","author":"A Akirov","year":"2022","unstructured":"A. Akirov, I. Shimon, M. Fleseriu, I. Dotan, Y. Manisterski, N. Aviran-Barak et al., Clinical study and systematic review of pituitary microadenomas vs. macroadenomas in Cushing\u2019s disease: does size matter?. J. Clin. Med. 11, 1558 (2022).","journal-title":"J. Clin. Med."},{"key":"4234_CR13","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s11102-011-0347-7","volume":"15","author":"F Roelfsema","year":"2012","unstructured":"F. Roelfsema, N.R. Biermasz, A.M. Pereira, Clinical factors involved in the recurrence of pituitary adenomas after surgical remission: a structured review and meta-analysis. Pituitary 15, 71\u201383 (2012).","journal-title":"Pituitary"},{"key":"4234_CR14","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1227\/neu.0000000000003042","volume":"95","author":"MC Findlay","year":"2024","unstructured":"M.C. Findlay, S. Tenhoeve, J. Alt, R.C. Rennert, W.T. Couldwell, J. Evans et al., Predictors of durable remission after successful surgery for cushing disease: results from the multicenter RAPID registry. Neurosurgery 95, 761\u2013769 (2024).","journal-title":"Neurosurgery"},{"key":"4234_CR15","doi-asserted-by":"publisher","first-page":"3287","DOI":"10.1210\/clinem\/dgad347","volume":"108","author":"MP Catalino","year":"2023","unstructured":"M.P. Catalino, D.T. Moore, N. Ironside, A.R. Munoz, J. Coley, R. Jonas et al., Postoperative serum cortisol and cushing disease recurrence in patients with corticotroph adenomas. J. Clin. Endocrinol. Metab. 108, 3287\u20133294 (2023).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4234_CR16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1530\/EO-21-0026","volume":"2","author":"A Stroud","year":"2022","unstructured":"A. Stroud, P. Dhaliwal, R.J. Harvey, R. Alvarado, B.P. Jonker, M.J. Winder et al., Low but not undetectable early postoperative nadir serum cortisol predicts sustained remission in Cushing\u2019s disease. Endocr. Oncol. 2, 19\u201331 (2022).","journal-title":"Endocr. Oncol."},{"key":"4234_CR17","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1210\/jc.2007-2013","volume":"93","author":"CG Patil","year":"2008","unstructured":"C.G. Patil, D.M. Prevedello, S.P. Lad, M.L. Vance, M.O. Thorner, L. Katznelson et al., Late recurrences of Cushing\u2019s disease after initial successful transsphenoidal surgery. J. Clin. Endocrinol. Metab. 93, 358\u2013362 (2008).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4234_CR18","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1159\/000496753","volume":"108","author":"Y Liu","year":"2019","unstructured":"Y. Liu, X. Liu, X. Hong, P. Liu, X. Bao, Y. Yao et al., Prediction of recurrence after transsphenoidal surgery for Cushing\u2019s disease: the use of machine learning algorithms. Neuroendocrinology 108, 201\u2013210 (2019).","journal-title":"Neuroendocrinology"},{"key":"4234_CR19","doi-asserted-by":"publisher","unstructured":"A. Albani, L.G. P\u00e9rez-Rivas, C. Dimopoulou, S. Zopp, P. Col\u00f3n-Bolea, S. Roeber, et al., The USP8 mutational status may predict long-term remission in patients with Cushing\u2019s disease. Clin. Endocrinol. (2018). https:\/\/doi.org\/10.1111\/cen.13802","DOI":"10.1111\/cen.13802"},{"key":"4234_CR20","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1007\/s11102-011-0295-2","volume":"14","author":"L Srinivasan","year":"2011","unstructured":"L. Srinivasan, E.R. Laws, R.L. Dodd, M.M. Monita, C.E. Tannenbaum, K.M. Kirkeby et al., The dynamics of post-operative plasma ACTH values following transsphenoidal surgery for Cushing\u2019s disease. Pituitary 14, 312\u2013317 (2011).","journal-title":"Pituitary"},{"key":"4234_CR21","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1210\/clinem\/dgad309","volume":"108","author":"R Alvarez","year":"2023","unstructured":"R. Alvarez, E. Hogan, D.T. Asuzu, T. Wu, G. Oshegbo, R. McGlotten et al., Diurnal range and intra-patient variability of ACTH is restored with remission in Cushing\u2019s disease. J. Clin. Endocrinol. Metab. 108, 2812\u20132820 (2023).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4234_CR22","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1530\/EC-17-0175","volume":"6","author":"P Bansal","year":"2017","unstructured":"P. Bansal, A. Lila, M. Goroshi, S. Jadhav, N. Lomte, K. Thakkar et al., Duration of post-operative hypocortisolism predicts sustained remission after pituitary surgery for Cushing\u2019s disease. Endocr. Connect. 6, 625\u2013636 (2017).","journal-title":"Endocr. Connect."},{"key":"4234_CR23","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1530\/EJE-12-0921","volume":"168","author":"KI Alexandraki","year":"2013","unstructured":"K.I. Alexandraki, G.A. Kaltsas, A.M. Isidori, H.L. Storr, F. Afshar, I. Sabin et al., Long-term remission and recurrence rates in Cushing\u2019s disease: predictive factors in a single-centre study. Eur. J. Endocrinol. 168, 639\u2013648 (2013).","journal-title":"Eur. J. Endocrinol."},{"key":"4234_CR24","doi-asserted-by":"publisher","first-page":"3383","DOI":"10.1210\/jc.2007-0208","volume":"92","author":"N Pouratian","year":"2007","unstructured":"N. Pouratian, D.M. Prevedello, J. Jagannathan, M.B. Lopes, M.L. Vance, E.R. Laws, Outcomes and management of patients with Cushing\u2019s disease without pathological confirmation of tumor resection after transsphenoidal surgery. J. Clin. Endocrinol. Metab. 92, 3383\u20133388 (2007).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4234_CR25","first-page":"440","volume":"84","author":"C Invitti","year":"1999","unstructured":"C. Invitti, F. Pecori Giraldi, M. de Martin, F. Cavagnini, Diagnosis and management of Cushing\u2019s syndrome: results of an Italian multicentre study. Study group of the Italian society of endocrinology on the pathophysiology of the hypothalamic-pituitary-adrenal axis. J. Clin. Endocrinol. Metab. 84, 440\u2013448 (1999).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4234_CR26","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.3390\/cancers11111761","volume":"11","author":"S Sbiera","year":"2019","unstructured":"S. Sbiera, M. Kunz, I. Weigand, T. Deutschbein, T. Dandekar, M. Fassnacht, The new genetic landscape of cushing\u2019s disease: deubiquitinases in the spotlight. Cancers 11, 1761 (2019).","journal-title":"Cancers"},{"key":"4234_CR27","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/cen.15065","volume":"101","author":"H Miao","year":"2024","unstructured":"H. Miao, L. Wang, F. Gong, L. Duan, Y. Yao, M. Feng et al., A long-term prognosis study of human USP8-mutated ACTH-secreting pituitary neuroendocrine tumours. Clin. Endocrinol. 101, 32\u201341 (2024).","journal-title":"Clin. Endocrinol."},{"key":"4234_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1302667","volume":"15","author":"M P\u0119kul","year":"2024","unstructured":"M. P\u0119kul, M. Szczepaniak, P. Kober, N. Rusetska, B.J. Mossakowska, S. Baluszek et al., Relevance of mutations in protein deubiquitinases genes and TP53 in corticotroph pituitary tumors. Front. Endocrinol. 15, 1302667 (2024).","journal-title":"Front. Endocrinol."},{"key":"4234_CR29","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.coemr.2018.02.001","volume":"1","author":"LE Wildemberg","year":"2018","unstructured":"L.E. Wildemberg, L. Kasuki, M.R. Gadelha, Precision medicine in the medical management of pituitary tumors. Curr. Opin. Endocr. Metab. Res. 1, 57\u201362 (2018).","journal-title":"Curr. Opin. Endocr. Metab. Res."},{"key":"4234_CR30","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1210\/clinem\/dgab125","volume":"106","author":"LE Wildemberg","year":"2021","unstructured":"L.E. Wildemberg, A.H. da Silva Camacho, R.L. Miranda, P.C.L. Elias, N.R. de Castro Musolino, D. Nazato et al., Machine learning-based prediction model for treatment of acromegaly with first-generation somatostatin receptor ligands. J. Clin. Endocrinol. Metab. 106, 2047\u20132056 (2021).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4234_CR31","doi-asserted-by":"publisher","DOI":"10.1111\/jne.13186","volume":"34","author":"L Guignat","year":"2022","unstructured":"L. Guignat, J. Bertherat, Long-term follow-up and predictors of recurrence of Cushing\u2019s disease. J. Neuroendocrinol. 34, e13186 (2022).","journal-title":"J. Neuroendocrinol."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04234-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-025-04234-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04234-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T06:49:24Z","timestamp":1751611764000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-025-04234-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,21]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["4234"],"URL":"https:\/\/doi.org\/10.1007\/s12020-025-04234-7","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,21]]},"assertion":[{"value":"12 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"L.E.W., L.K. and M.R.G. have received speaker fees from Recordati Rare Diseases. M.R.G. attended advisory boards for Recordati Rare Diseases. The other authors have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the local Ethics Committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}